These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9315987)

  • 41. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
    Winokur A; DeMartinis NA; McNally DP; Gary EM; Cormier JL; Gary KA
    J Clin Psychiatry; 2003 Oct; 64(10):1224-9. PubMed ID: 14658972
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R; da Silva Telles RM; Alves TC; Andrei AM; Rays J; Iosifescu DV; Wajngarten M
    Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetine.
    Tollefson GD; Sayler ME
    Depress Anxiety; 1996-1997; 4(6):294-311. PubMed ID: 9166658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
    Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
    Keller MB; Trivedi MH; Thase ME; Shelton RC; Kornstein SG; Nemeroff CB; Friedman ES; Gelenberg AJ; Kocsis JH; Dunner DL; Hirschfeld RM; Rothschild AJ; Ferguson JM; Schatzberg AF; Zajecka JM; Pedersen RD; Yan B; Ahmed S; Musgnung J; Ninan PT
    J Clin Psychiatry; 2007 Aug; 68(8):1246-56. PubMed ID: 17854250
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
    Levitan RD; Shen JH; Jindal R; Driver HS; Kennedy SH; Shapiro CM
    J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluoxetine discontinuation in elderly dysthymic patients.
    Devanand DP; Kim MK; Nobler MS
    Am J Geriatr Psychiatry; 1997; 5(1):83-7. PubMed ID: 9169249
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine.
    Maes M; Westenberg H; Vandoolaeghe E; Demedts P; Wauters A; Neels H; Meltzer HY
    J Clin Psychopharmacol; 1997 Oct; 17(5):358-64. PubMed ID: 9315986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Moclobemide and fluoxetine in treatment of seasonal affective disorder.
    Partonen T; Lönnqvist J
    J Affect Disord; 1996 Nov; 41(2):93-9. PubMed ID: 8961036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized double-blind comparison of fluoxetine augmentation by high and low dosage folic acid in patients with depressive episodes.
    Venkatasubramanian R; Kumar CN; Pandey RS
    J Affect Disord; 2013 Sep; 150(2):644-8. PubMed ID: 23507369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of fluoxetine remission for hospitalized patients with major depressive disorder.
    Lin CH; Lane HY; Chen CC; Juo SH; Yen CF
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):510-7. PubMed ID: 21851460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of fluoxetine on weight gain and food intake in smokers who reduce nicotine intake.
    Pomerleau OF; Pomerleau CS; Morrell EM; Lowenbergh JM
    Psychoneuroendocrinology; 1991; 16(5):433-40. PubMed ID: 1805294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Naturalistic study of the weight effects of amitriptyline, fluoxetine, and sertraline in an outpatient medical setting.
    Sansone RA; Wiederman MW; Shrader JA
    J Clin Psychopharmacol; 2000 Apr; 20(2):272-4. PubMed ID: 10770474
    [No Abstract]   [Full Text] [Related]  

  • 56. Photosensitivity reaction to fluoxetine and alprazolam.
    Pazzagli L; Banfi R; Borselli G; Semmola MV
    Pharm World Sci; 1998 Jun; 20(3):136. PubMed ID: 9618738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of Fluoxetine to Reduce Weight in Adults with Overweight or Obesity: Abridged Republication of the Cochrane Systematic Review.
    Serralde-Zuñiga AE; González-Garay AG; Rodríguez-Carmona Y; Meléndez-Mier G
    Obes Facts; 2022; 15(4):473-486. PubMed ID: 35654016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fluoxetine for adults who are overweight or obese.
    Serralde-Zúñiga AE; Gonzalez Garay AG; Rodríguez-Carmona Y; Melendez G
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD011688. PubMed ID: 31613390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly.
    Draper B; Berman K
    Drugs Aging; 2008; 25(6):501-19. PubMed ID: 18540689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antidepressant versus placebo for depressed elderly.
    Wilson K; Mottram P; Sivanranthan A; Nightingale A
    Cochrane Database Syst Rev; 2001; 2001(2):CD000561. PubMed ID: 11405969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.